aloselim
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for aloselim, covering 2019-06-13 to 2019-06-13. Get the full timeline:
Most recent: Clinical Trial Update: Early Alirocumab to Reduce LDL-C in Myocardial Infarction [Phase 4]